rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Paolo Pucci

Director

Company insider

Files Form 4 as: Director, West Pharmaceutical Services; Director, Replimune Group; Director, Merus; Director, Trillium Therapeutics; Chief Executive Officer, Arqule; Director, Newlink Genetics; Director and Other, Dyax.

Every Form 4 they filed

In numbers

Trades disclosed
126
Buys
23
Sells
1
Bought
$314K
Sold
$206K
Companies
7
Companies where not an officer
6
First trade
9 Jun 2008
Last trade
4 May 2026
Last filed
6 May 2026

Companies traded

Where they are an officer
ArquleDirector, Officer, Other · last 16 Jan 202023 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
WST West Pharmaceutical ServicesDirector · Medical Devices · last 4 May 20260 buys · 0 sells
REPL Replimune GroupDirector · Biotechnology · last 1 Apr 20260 buys · 0 sells
MerusDirector · last 12 Dec 20250 buys · 0 sells
Trillium TherapeuticsDirector · last 17 Nov 20210 buys · 0 sells
Newlink GeneticsDirector · last 23 May 20180 buys · 0 sells
DyaxDirector, Other · last 22 Jan 20160 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 May 2026filed 6 May 2026WST West Pharmaceutical ServicesMedical DevicesSEC FORM 4 Code A—791 at $0.00filing
4 May 2026filed 6 May 2026WST West Pharmaceutical ServicesMedical DevicesSEC FORM 4 Code A—791 at $0.00filing
1 Apr 2026filed 7 Apr 2026REPL Replimune Groupoption or derivative · BiotechnologySEC FORM 4 Code A—44,500 at $0.00filing
1 Apr 2026filed 7 Apr 2026REPL Replimune Groupoption or derivative · BiotechnologySEC FORM 4 Code A—44,500 at $0.00filing
12 Dec 2025filed 12 Dec 2025Merusoption or derivativeSEC FORM 4 Code D—13,193 at $0.00filing
12 Dec 2025filed 12 Dec 2025Merusoption or derivativeSEC FORM 4 Code D—8,844 at $0.00filing
12 Dec 2025filed 12 Dec 2025Merusoption or derivativeSEC FORM 4 Code D—14,414 at $0.00filing
12 Dec 2025filed 12 Dec 2025Merusoption or derivativeSEC FORM 4 Code D—16,604 at $0.00filing
12 Dec 2025filed 12 Dec 2025Merusoption or derivativeSEC FORM 4 Code D—6,120 at $0.00filing
12 Dec 2025filed 12 Dec 2025Merusoption or derivativeSEC FORM 4 Code D—17,262 at $0.00filing
22 May 2025filed 27 May 2025Merusoption or derivativeSEC FORM 4 Code A—13,193 at $0.00filing
6 May 2025filed 8 May 2025WST West Pharmaceutical ServicesMedical DevicesSEC FORM 4 Code A—1,071 at $0.00filing
1 Apr 2025filed 3 Apr 2025REPL Replimune Groupoption or derivative · BiotechnologySEC FORM 4 Code A—32,000 at $0.00filing
7 May 2024filed 9 May 2024Merusoption or derivativeSEC FORM 4 Code A—8,844 at $0.00filing
23 Apr 2024filed 25 Apr 2024WST West Pharmaceutical ServicesMedical DevicesSEC FORM 4 Code A—564 at $0.00filing
1 Apr 2024filed 3 Apr 2024REPL Replimune Groupoption or derivative · BiotechnologySEC FORM 4 Code A—32,000 at $0.00filing
8 Jun 2023filed 12 Jun 2023Merusoption or derivativeSEC FORM 4 Code A—14,414 at $0.00filing
25 Apr 2023filed 27 Apr 2023WST West Pharmaceutical ServicesMedical DevicesSEC FORM 4 Code A—616filing
1 Apr 2023filed 4 Apr 2023REPL Replimune Groupoption or derivative · BiotechnologySEC FORM 4 Code A—25,200 at $0.00filing
31 May 2022filed 2 Jun 2022Merusoption or derivativeSEC FORM 4 Code A—16,604 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed24

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.